Article Sidebar
Views pdf: 86
EARLY RESULTS OF THE REGIMEN FCR FOR TREATING CLL PATIENTS IN THE NATIONAL INSTITUE OF HEMATOLOGY AND BLOOD TRANSFUSION
Main Article Content
Abstract
The objective of this study is to evaluate the clinical characteristics, laboratory tests, and treatment results of patients with Chronic lymphocytic Leukemia (CLL) who were treated with the FCR regimen at the National Institute of Hematology and Blood Transfusion (NIHBT) The study was conducted on 30 patients who were diagnosed with CLL and treated initially at NIHBT, from 9/2016 to 6/2019 and this is an intervention and prospective study. The study result showed the overall response rate was 86.7%, in which the complete response rate was 66.7%, the partial response rate was 20%, and 13.3% of patients with no response. Hematological side effects were neutropenia accounting for 70% and thrombocytopenia accounting for 46.7%. Other side effects were nausea accounting for 43.3% and infection accounting for 13.3%.
Article Details
Keywords
Chronic lymphocytic Leukemia (CLL), FCR.
References
2. Đỗ Trung Phấn (2003), Leukemia mạn dòng lympho - bệnh lý dòng lympho B, Bệnh lý tế bào nguồn tạo máu, Nhà xuất bản Y học, Hà nội, Tr.317-323.
3. Hallek M (2008), Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines, Blood, 15 June, 2008, Volume 111, number 12
4. Thomas J.Kipps (1995), “Chronic lymphocytic leukemia and related diseases”, William Hematology, Califorlia, pp. 1431-1481.
5. Đỗ Trung Phấn (2004), Bệnh lý tăng sinh lympho mạn ác tính, Bài giảng Huyết học - Truyền máu, Nhà xuất bản Y học, Hà nội, Tr.133-139.
6. Phạm Quang Vinh (2013), Bất thường di truyền tế bào và bệnh máu ác tính, Nhà xuất bản Y học, Hà nội, Tr 184-206